Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

bone invasion

  • You have access
    Implications of TP-positive CAFs in the Bone Invasion of Oral Squamous Cell Carcinoma
    AIHUA GAO, DONG WOOK KIM, MEILING PEI, KI-YEOL KIM, YOUNG-JIN PARK, WOONG NAM, HYUNG JUN KIM, HYUN SIL KIM, IN-HO CHA and XIANGLAN ZHANG
    Anticancer Research August 2024, 44 (8) 3365-3374; DOI: https://doi.org/10.21873/anticanres.17157
  • You have access
    The Prognostic Implications of Bone Invasion in Gingival Squamous Cell Carcinoma
    SHOKO YOSHIDA, TSUYOSHI SHIMO, YURIKA MURASE, KIYOFUMI TAKABATAKE, KOJI KISHIMOTO, SOICHIRO IBARAGI, NORIE YOSHIOKA, TATSUO OKUI, HITOSHI NAGATSUKA and AKIRA SASAKI
    Anticancer Research February 2018, 38 (2) 955-962;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire